4//SEC Filing
Myers Thomas Richard 4
Accession 0001209191-22-052235
CIK 0001006028other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:27 PM ET
Size
8.1 KB
Accession
0001209191-22-052235
Insider Transaction Report
Form 4
Myers Thomas Richard
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-30+125,000→ 125,000 totalExercise: $0.20Exp: 2032-09-30→ Common Stock (125,000 underlying) - Award
Stock Option (Right to Buy)
2022-09-30+125,000→ 125,000 totalExercise: $0.20Exp: 2032-09-30→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024.
- [F2]The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001755512
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:27 PM ET
- Size
- 8.1 KB